- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
SMS Pharmaceuticals Limited — Updates, 09-02-2026: Press Release
09-02-2026 | 07:23 pm
09-02-2026 | 07:23 pm
SMS Pharma reported robust Q3 results: revenue +21% (₹210.45 Cr), EBITDA +31% (₹43.65 Cr), PAT +29% (₹23.47 Cr). 9M PAT surged 42%. The company met its R&D filing target early and its ₹280 Cr Capex is on schedule. FY26 outlook remains strong.
No comments yet. Be the first to comment!